Stay updated with breaking news from Commercial Launch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Working with a Major Global Payment Network to Deliver its Advanced Biometric Payment Card Protection for a Commercial Launch is SmartMetric, Stock Symbol: SMME
Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights Over 250 patient start forms received by the end of the first quarter – – Cash and cash equivalents, and investments of $360.9 million at March 31, 2021 – – Conference call to be hosted today at 5:00 p.m. ET – Aurinia Pharmaceuticals Inc. today issued its financial results for the first quarter ended March 31, 2021. Amounts, unless specified otherwise, are expressed in U.S. dollars. “2021 started with the FDA … – Over 250 patient start forms received by the end of the first quarter – ...
Avinger Reports First Quarter 2021 Financial Results ACCESSWIRE 13% Year-over-Year Revenue Growth Driven by Tigereye™ Commercial Launch and Pantheris SV Sales Growth REDWOOD CITY, CA / ACCESSWIRE / May 6, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today reported results for the first quarter ended March 31, 2021. First Quarter and Recent Highlights Revenue increased 13% year-over-year to $2.6 million, reflecting co...
Share: Commercial Launch of VAZKEPA in Europe on Track to Commence in Q3 2021 Following Recent Market Authorization with VASCEPA® Growth in the United States Positioned to Increase as the Impact of COVID-19 Recedes Expenses Managed in Q1 2021 to Minimize Operating Loss Despite Revenue Impact of COVID-19 and Other Factors Management to Host Conference Call Today at 7:30 a.m. ET DUBLIN, Ireland and BRIDGEWATER, N.J., April 29, 2021 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), today announced financial results for the quarter ended March 31, 2021 and provided an update on compan...
Share this article SUNNYVALE, Calif., April 14, 2021 /PRNewswire/ -- Lore IO, Inc., providers of an AI-powered common data model that enables faster data onboarding and unified data views, today announced the immediate availability of its freemium offering of Lore IO Pre-Commercial Launch Analytics. The offering helps emerging biopharma companies accelerate their pre-commercial launch planning by providing them with faster data onboarding, data transformation, and customizable dashboards. The announcement also marks the first pre-launch commercial analytics offering in Lore IO's Life Scien...